{"id":75755,"date":"2026-08-21T12:03:50","date_gmt":"2026-08-21T04:03:50","guid":{"rendered":"https:\/\/flcube.com\/?p=75755"},"modified":"2026-08-21T12:03:51","modified_gmt":"2026-08-21T04:03:51","slug":"genentech-pledges-usd-750-million-for-oregon-device-fill-finish-plant-expanding-roches-u-s-manufacturing-footprint","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=75755","title":{"rendered":"Genentech Pledges USD 750 Million for Oregon Device Fill\u2011Finish Plant, Expanding Roche&#8217;s U.S. Manufacturing Footprint"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Genentech<\/strong>, a wholly owned subsidiary of <strong>Roche Holding AG<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/beta\/quote\/ROP:SWX\">SWX: ROP<\/a>; <a href=\"https:\/\/www.google.com\/finance\/beta\/quote\/RHHBY:OTCMKTS\">OTCMKTS: RHHBY<\/a>), announced plans to invest <strong>USD 750 million<\/strong> in a new <strong>device fill\u2011finish manufacturing facility<\/strong> in <strong>Oregon, U.S.<\/strong> The project will deliver new end\u2011to\u2011end device\u2011filling capabilities and expand capacity to support the future pipeline of innovative medicines across both <strong>Roche<\/strong> and <strong>Genentech<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-investment-milestone\" class=\"wp-block-heading\">Investment Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Investor<\/strong><\/td><td>Genentech (Roche wholly owned subsidiary)<\/td><\/tr><tr><td><strong>Investment Size<\/strong><\/td><td>USD 750 million<\/td><\/tr><tr><td><strong>Facility Type<\/strong><\/td><td>Device fill\u2011finish manufacturing site<\/td><\/tr><tr><td><strong>Location<\/strong><\/td><td>Oregon, United States<\/td><\/tr><tr><td><strong>Capability Added<\/strong><\/td><td>End\u2011to\u2011end device filling<\/td><\/tr><tr><td><strong>Jobs Created<\/strong><\/td><td>~250 high\u2011wage manufacturing + ~200 construction roles<\/td><\/tr><tr><td><strong>Commercial Operations<\/strong><\/td><td>Expected to begin 2031<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-strategic-rationale-amp-facility-profile\" class=\"wp-block-heading\">Strategic Rationale &amp; Facility Profile<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Purpose:<\/strong> Expand capacity for next\u2011generation device\u2011delivered medicines across the combined <strong>Roche\u2011Genentech<\/strong> pipeline<\/li>\n\n\n\n<li><strong>Capability:<\/strong> First end\u2011to\u2011end device\u2011filling operations at the Oregon site, reducing reliance on external contract manufacturing<\/li>\n\n\n\n<li><strong>Parent Context:<\/strong> Strengthens <strong>Roche&#8217;s<\/strong> U.S. manufacturing base amid ongoing industry push to onshore production of complex biologics and device\u2011drug combinations<\/li>\n\n\n\n<li><strong>Timeline:<\/strong> Site development underway, with commercial production targeted for <strong>2031<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-economic-amp-labor-impact\" class=\"wp-block-heading\">Economic &amp; Labor Impact<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Metric<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>High\u2011Wage Manufacturing Jobs<\/strong><\/td><td>~250 permanent positions<\/td><\/tr><tr><td><strong>Construction Jobs<\/strong><\/td><td>~200 roles during site development<\/td><\/tr><tr><td><strong>Regional Benefit<\/strong><\/td><td>Oregon workforce expansion in advanced pharmaceutical manufacturing<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The investment is expected to generate approximately <strong>250 high\u2011wage manufacturing jobs<\/strong> and roughly <strong>200 construction jobs<\/strong> in Oregon during the development phase, reinforcing the state&#8217;s position in advanced pharmaceutical manufacturing.<\/p>\n\n\n\n<h2 id=\"h-market-impact-amp-outlook\" class=\"wp-block-heading\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Supply\u2011Chain Resilience:<\/strong> The facility gives <strong>Roche<\/strong> and <strong>Genentech<\/strong> greater control over device\u2011based delivery formats, a growing category as the pipeline shifts toward combination drug\u2011device therapies<\/li>\n\n\n\n<li><strong>U.S. Onshoring Trend:<\/strong> Aligns with broader industry momentum to repatriate pharmaceutical manufacturing capacity to the United States amid policy and tariff pressures<\/li>\n\n\n\n<li><strong>Pipeline Support:<\/strong> Expanded fill\u2011finish capacity is positioned to serve late\u2011stage and future commercial products, potentially accelerating launch timelines for device\u2011delivered medicines<\/li>\n\n\n\n<li><strong>Competitive Position:<\/strong> In\u2011house device filling strengthens <strong>Roche&#8217;s<\/strong> end\u2011to\u2011end manufacturing flexibility relative to peers reliant on third\u2011party fill\u2011finish providers<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding capital investment, facility timelines, job creation, and manufacturing capacity for Genentech and Roche. Actual results may differ due to risks including construction schedules, regulatory approvals, and commercial demand for device\u2011delivered products.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Genentech, a wholly owned subsidiary of Roche Holding AG (SWX: ROP; OTCMKTS: RHHBY), announced plans&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7],"tags":[1111,940,163,939],"class_list":["post-75755","post","type-post","status-publish","format-standard","hentry","category-company","tag-genentech","tag-otcmkts-rhhby","tag-roche","tag-swx-rop"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Genentech Pledges USD 750 Million for Oregon Device Fill\u2011Finish Plant, Expanding Roche&#039;s U.S. Manufacturing Footprint - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Genentech, a wholly owned subsidiary of Roche Holding AG (SWX: ROP; OTCMKTS: RHHBY), announced plans to invest USD 750 million in a new device fill\u2011finish manufacturing facility in Oregon, U.S. The project will deliver new end\u2011to\u2011end device\u2011filling capabilities and expand capacity to support the future pipeline of innovative medicines across both Roche and Genentech.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=75755\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Genentech Pledges USD 750 Million for Oregon Device Fill\u2011Finish Plant, Expanding Roche&#039;s U.S. Manufacturing Footprint\" \/>\n<meta property=\"og:description\" content=\"Genentech, a wholly owned subsidiary of Roche Holding AG (SWX: ROP; OTCMKTS: RHHBY), announced plans to invest USD 750 million in a new device fill\u2011finish manufacturing facility in Oregon, U.S. The project will deliver new end\u2011to\u2011end device\u2011filling capabilities and expand capacity to support the future pipeline of innovative medicines across both Roche and Genentech.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=75755\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-21T04:03:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-21T04:03:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75755#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75755\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Genentech Pledges USD 750 Million for Oregon Device Fill\u2011Finish Plant, Expanding Roche&#8217;s U.S. Manufacturing Footprint\",\"datePublished\":\"2026-08-21T04:03:50+00:00\",\"dateModified\":\"2026-08-21T04:03:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75755\"},\"wordCount\":395,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Genentech\",\"OTCMKTS: RHHBY\",\"Roche\",\"SWX: ROP\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=75755#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75755\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=75755\",\"name\":\"Genentech Pledges USD 750 Million for Oregon Device Fill\u2011Finish Plant, Expanding Roche's U.S. Manufacturing Footprint - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-08-21T04:03:50+00:00\",\"dateModified\":\"2026-08-21T04:03:51+00:00\",\"description\":\"Genentech, a wholly owned subsidiary of Roche Holding AG (SWX: ROP; OTCMKTS: RHHBY), announced plans to invest USD 750 million in a new device fill\u2011finish manufacturing facility in Oregon, U.S. The project will deliver new end\u2011to\u2011end device\u2011filling capabilities and expand capacity to support the future pipeline of innovative medicines across both Roche and Genentech.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75755#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=75755\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75755#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Genentech Pledges USD 750 Million for Oregon Device Fill\u2011Finish Plant, Expanding Roche&#8217;s U.S. Manufacturing Footprint\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Genentech Pledges USD 750 Million for Oregon Device Fill\u2011Finish Plant, Expanding Roche's U.S. Manufacturing Footprint - Insight, China&#039;s Pharmaceutical Industry","description":"Genentech, a wholly owned subsidiary of Roche Holding AG (SWX: ROP; OTCMKTS: RHHBY), announced plans to invest USD 750 million in a new device fill\u2011finish manufacturing facility in Oregon, U.S. The project will deliver new end\u2011to\u2011end device\u2011filling capabilities and expand capacity to support the future pipeline of innovative medicines across both Roche and Genentech.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=75755","og_locale":"en_US","og_type":"article","og_title":"Genentech Pledges USD 750 Million for Oregon Device Fill\u2011Finish Plant, Expanding Roche's U.S. Manufacturing Footprint","og_description":"Genentech, a wholly owned subsidiary of Roche Holding AG (SWX: ROP; OTCMKTS: RHHBY), announced plans to invest USD 750 million in a new device fill\u2011finish manufacturing facility in Oregon, U.S. The project will deliver new end\u2011to\u2011end device\u2011filling capabilities and expand capacity to support the future pipeline of innovative medicines across both Roche and Genentech.","og_url":"https:\/\/flcube.com\/?p=75755","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-08-21T04:03:50+00:00","article_modified_time":"2026-08-21T04:03:51+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=75755#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=75755"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Genentech Pledges USD 750 Million for Oregon Device Fill\u2011Finish Plant, Expanding Roche&#8217;s U.S. Manufacturing Footprint","datePublished":"2026-08-21T04:03:50+00:00","dateModified":"2026-08-21T04:03:51+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=75755"},"wordCount":395,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Genentech","OTCMKTS: RHHBY","Roche","SWX: ROP"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=75755#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=75755","url":"https:\/\/flcube.com\/?p=75755","name":"Genentech Pledges USD 750 Million for Oregon Device Fill\u2011Finish Plant, Expanding Roche's U.S. Manufacturing Footprint - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-08-21T04:03:50+00:00","dateModified":"2026-08-21T04:03:51+00:00","description":"Genentech, a wholly owned subsidiary of Roche Holding AG (SWX: ROP; OTCMKTS: RHHBY), announced plans to invest USD 750 million in a new device fill\u2011finish manufacturing facility in Oregon, U.S. The project will deliver new end\u2011to\u2011end device\u2011filling capabilities and expand capacity to support the future pipeline of innovative medicines across both Roche and Genentech.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=75755#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=75755"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=75755#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Genentech Pledges USD 750 Million for Oregon Device Fill\u2011Finish Plant, Expanding Roche&#8217;s U.S. Manufacturing Footprint"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/75755","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=75755"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/75755\/revisions"}],"predecessor-version":[{"id":75757,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/75755\/revisions\/75757"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=75755"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=75755"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=75755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}